Neuronetics Historical Financial Ratios
| STIM Stock | USD 0.89 0.05 5.95% |
Neuronetics is lately reporting on over 100 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Book Value Per Share of 1.25, Invested Capital of 0.0, Average Payables of 0.0 or Stock Based Compensation To Revenue of 0.0574 will help investors to properly organize and evaluate Neuronetics financial condition quickly.
Neuronetics |
About Neuronetics Financial Ratios Analysis
NeuroneticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Neuronetics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Neuronetics financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Neuronetics history.
Neuronetics Financial Ratios Chart
Add Fundamental
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Neuronetics stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Neuronetics sales, a figure that is much harder to manipulate than other Neuronetics multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Ev To Sales
The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.Inventory Turnover
A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.Earnings Yield
The inverse of the price-to-earnings ratio, representing the percentage of each dollar invested in the stock that was earned by the company.Current Ratio
A liquidity ratio that measures a company's ability to pay short-term obligations or those due within one year. It compares a firm's current assets to its current liabilities.Most ratios from Neuronetics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Neuronetics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.At this time, Neuronetics' Intangibles To Total Assets are very stable compared to the past year. As of the 22nd of November 2024, Tangible Book Value Per Share is likely to grow to 1.10, while Free Cash Flow Yield is likely to drop (0.43).
| 2021 | 2022 | 2023 | 2024 (projected) | Payables Turnover | 2.71 | 6.36 | 4.13 | 3.12 | Days Of Inventory On Hand | 205.57 | 209.79 | 150.38 | 100.74 |
Neuronetics fundamentals Correlations
Click cells to compare fundamentals
Neuronetics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Neuronetics fundamentals Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Price To Sales Ratio | 1.32 | 4.25 | 2.05 | 2.83 | 1.16 | 1.49 | |
| Ptb Ratio | 1.72 | 8.21 | 1.33 | 3.24 | 2.43 | 1.94 | |
| Days Sales Outstanding | 38.27 | 53.11 | 51.34 | 77.37 | 91.26 | 95.82 | |
| Book Value Per Share | 2.6 | 1.35 | 3.34 | 2.12 | 1.19 | 1.25 | |
| Free Cash Flow Yield | (0.38) | (0.14) | (0.27) | (0.18) | (0.41) | (0.43) | |
| Operating Cash Flow Per Share | (1.66) | (1.51) | (1.1) | (1.14) | (1.12) | (1.17) | |
| Stock Based Compensation To Revenue | 0.0548 | 0.0894 | 0.14 | 0.13 | 0.1 | 0.0574 | |
| Capex To Depreciation | 0.76 | 0.78 | 2.22 | 1.98 | 1.18 | 0.95 | |
| Pb Ratio | 1.72 | 8.21 | 1.33 | 3.24 | 2.43 | 1.94 | |
| Ev To Sales | 0.66 | 4.03 | 1.07 | 2.36 | 1.2 | 1.13 | |
| Free Cash Flow Per Share | (2.41) | (1.7) | (1.55) | (1.19) | (1.26) | (1.2) | |
| Roic | (0.4) | (0.43) | (0.26) | (0.39) | (0.32) | (0.34) | |
| Inventory Turnover | 5.55 | 3.11 | 1.78 | 1.74 | 2.43 | 3.78 | |
| Net Income Per Share | (1.87) | (1.71) | (1.4) | (1.46) | (1.05) | (1.11) | |
| Days Of Inventory On Hand | 65.82 | 117.52 | 205.57 | 209.79 | 150.38 | 100.74 | |
| Payables Turnover | 3.33 | 3.08 | 2.71 | 6.36 | 4.13 | 3.12 | |
| Sales General And Administrative To Revenue | 0.26 | 0.28 | 0.37 | 0.46 | 0.39 | 0.36 | |
| Research And Ddevelopement To Revenue | 0.2 | 0.16 | 0.22 | 0.19 | 0.14 | 0.13 | |
| Capex To Revenue | 0.013 | 0.0148 | 0.0425 | 0.0501 | 0.0332 | 0.0197 | |
| Cash Per Share | 4.17 | 2.7 | 3.78 | 2.67 | 2.11 | 2.01 | |
| Pocfratio | (2.71) | (7.37) | (4.06) | (6.01) | (2.59) | (2.72) | |
| Interest Coverage | (7.31) | (4.93) | (6.86) | (8.26) | (5.63) | (5.91) | |
| Capex To Operating Cash Flow | (0.0267) | (0.0257) | (0.0841) | (0.11) | (0.0739) | (0.0776) | |
| Pfcf Ratio | (2.64) | (7.19) | (3.75) | (5.43) | (2.42) | (2.54) | |
| Days Payables Outstanding | 109.7 | 118.43 | 134.66 | 57.36 | 88.3 | 109.38 | |
| Income Quality | 1.05 | 1.03 | 0.9 | 0.83 | 1.06 | 0.72 | |
| Roe | (0.72) | (1.27) | (0.42) | (0.69) | (0.88) | (0.93) | |
| Ev To Operating Cash Flow | (1.35) | (7.0) | (2.11) | (5.02) | (2.68) | (2.82) | |
| Pe Ratio | (2.41) | (6.48) | (3.19) | (4.71) | (2.75) | (2.89) | |
| Return On Tangible Assets | (0.42) | (0.21) | (0.35) | (0.26) | (0.27) | (0.28) | |
| Ev To Free Cash Flow | (1.31) | (6.82) | (1.95) | (4.53) | (2.5) | (2.62) | |
| Earnings Yield | (0.42) | (0.15) | (0.31) | (0.21) | (0.36) | (0.38) | |
| Intangibles To Total Assets | 0.012 | 0.0153 | 0.0177 | 0.0308 | 0.0363 | 0.0381 | |
| Net Debt To E B I T D A | 3.8 | 1.54 | 0.5 | 2.06 | 0.98 | (0.12) | |
| Current Ratio | 3.19 | 4.75 | 7.34 | 2.98 | 4.73 | 3.62 | |
| Tangible Book Value Per Share | 2.54 | 1.29 | 3.24 | 1.99 | 1.05 | 1.1 | |
| Receivables Turnover | 9.54 | 6.87 | 7.11 | 4.72 | 4.0 | 3.8 | |
| Graham Number | 10.46 | 7.22 | 10.25 | 8.34 | 5.32 | 5.05 | |
| Shareholders Equity Per Share | 2.6 | 1.35 | 3.34 | 2.12 | 1.19 | 1.25 | |
| Debt To Equity | 0.66 | 1.38 | 0.42 | 0.64 | 1.76 | 1.85 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.22) | Revenue Per Share 2.453 | Quarterly Revenue Growth (0.07) | Return On Assets (0.17) | Return On Equity (1.00) |
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.